Lifeline Biotechnologies, Inc. engages in the development and marketing of technology, applications, and medical devices. It is involved in the development of The First Warning System for assisting in the early detection of breast cancer. The company was founded by William Reeves in 1994 and is headquartered in Reno, NV.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Lifeline Biotechnologies Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Lifeline Biotechnologies Inc. market cap is $3.91M.
What is the 52-week high for Lifeline Biotechnologies Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Lifeline Biotechnologies Inc. 52 week high is $0.0013 as of October 04, 2025.
What is the 52-week low for Lifeline Biotechnologies Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Lifeline Biotechnologies Inc. 52 week low is $0.00 as of October 04, 2025.
What is Lifeline Biotechnologies Inc. stock price today?
Lifeline Biotechnologies Inc. stock price today is $0.0009.
What was Lifeline Biotechnologies Inc. stock price yesterday?
Lifeline Biotechnologies Inc. stock price yesterday was $0.0009.
What is the Price-to-Book ratio of Lifeline Biotechnologies Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Lifeline Biotechnologies Inc. P/B ratio is -45.
What is the 50-day moving average of Lifeline Biotechnologies Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Lifeline Biotechnologies Inc. 50-day moving average is $0.0005.